Back to Search
Start Over
Alpha 1-adrenoceptor vasoconstriction in the tail artery during ageing.
- Source :
-
British journal of pharmacology [Br J Pharmacol] 1997 Jul; Vol. 121 (5), pp. 1017-23. - Publication Year :
- 1997
-
Abstract
- 1. We have studied the alpha 1-adrenoceptor-mediated responses in intact tail artery rings from 3-4 and 20-22 months old Sprague-Dawley rats, focusing on possible endothelial alterations. The influence of nitric oxide released by the endothelium, the number of alpha 1-adrenoceptors and the functional receptor reserve were evaluated to determine their contribution to the contractile response mediated by this receptor. The state of the endothelial layer was assessed by confocal microscopy. 2. Noradrenaline (1 nM-100 microM) induced concentration-dependent vasoconstriction. The maximum contractions to noradrenaline (P < 0.05) and to 75 mM KCl (P < 0.01) were higher in young than in old animals. 3. The density (Bmax) of alpha 1-adrenoceptors and the dissociation constant (KD) obtained in [3H]-prazosin binding experiments were unchanged by age. 4. The apparent affinity (pKA) and the percentage of functional receptors (qx 100) remaining after phenoxybenzamine (0.03 microM) were similar in both age groups. 5. After partial alpha 1-adrenoceptor inactivation with phenoxybenzamine, NG-nitro-L-arginine methylester (30 microM) significantly potentiated the E/[A] curve to noradrenaline in young rats. However, only responses to 0.1 to 1 microM noradrenaline were significantly potentiated in old animals. In addition, 94% of the vessels from young, but only 52% from old rats were relaxed by 80-100% of the noradrenaline (0.03 microM) contraction, with 1 microM acetylcholine. 6. No modifications in the area (micron2) or in the number of endothelial nuclei (per mm2) were observed between age groups. An elongation of the nuclei of endothelial cells was observed in the old animals. 7. These data suggest that the noradrenaline-induced contraction is decreased in old rats probably due to differences in either the contractile machinary or postreceptor mechanisms. These alterations may be accompanied by an impairment of the release or production of NO from endothelial cells.
- Subjects :
- Adrenergic alpha-1 Receptor Agonists
Adrenergic alpha-1 Receptor Antagonists
Adrenergic alpha-Agonists pharmacology
Adrenergic alpha-Antagonists metabolism
Adrenergic alpha-Antagonists pharmacology
Animals
Endothelium, Vascular
Enzyme Inhibitors pharmacology
In Vitro Techniques
Kinetics
Male
Microscopy, Confocal
Muscle Contraction drug effects
Muscle Development
Muscle, Smooth, Vascular growth & development
NG-Nitroarginine Methyl Ester pharmacology
Nitric Oxide Synthase antagonists & inhibitors
Norepinephrine pharmacology
Prazosin metabolism
Prazosin pharmacology
Rats
Rats, Sprague-Dawley
Regional Blood Flow drug effects
Regional Blood Flow physiology
Tail blood supply
Tail growth & development
Aging physiology
Muscle, Smooth, Vascular drug effects
Receptors, Adrenergic, alpha-1 physiology
Vasoconstriction drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 0007-1188
- Volume :
- 121
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- British journal of pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 9222562
- Full Text :
- https://doi.org/10.1038/sj.bjp.0701193